Camelia Iancu-Rubin

Camelia Iancu-Rubin, PhD

  • ASSOCIATE PROFESSOR | Pathology, Molecular and Cell Based Medicine
  • ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology

Research Topics:

Blood, Cancer, Cell Biology, Differentiation, Fibrosis, Hematopoiesis, Leukemia, Molecular Biology, Translational Research

Dr. Iancu-Rubin completed her Bachelor and Master Degrees in Biology at the University of Bucharest in Romania. She pursued a career in clinical laboratory and teaching until 1997 when she became a Fulbright Scholar at the Mount Sinai Graduate School of Biomedical Sciences in New York. Dr. Iancu-Rubin received her Ph.D. in Life Sciences, Summa Cum Laude, from the University of Bucharest in 2000 and completed a 5-year postdoctoral fellowship in the Division of Hematology at Mount Sinai Medical Center in New York. She is currently an Associate Professor with appointments in the Department of Pathology, Molecular and Cell-Based Medicine (primary) and the Division of Hematology and Medical Oncology of the Tisch Cancer Institute (secondary) at Icahn School of Medicine at Mount Sinai. Dr. Iancu-Rubin has been lead investigator on NIH-funded, foundations and institutional projects as well as on industry-sponsored studies. Her research focuses on preclinical and clinical development of hematopoietic stem cell-based therapies (i.e. megakaryocytes and platelets) for patients with blood disorders. Dr. Iancu-Rubin is the Director of the Cellular Therapy Laboratory which supports hematopoietic stem cells transplantation services and other cell-based therapies at Mount Sinai Hospital in New York.


MS, University of Medicine and Pharmacy

PhD, University of Bucharest

Mount Sinai School of Medicine